Meftal TX (250+500) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Blue Cross Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Mefenamic Acid, Tranexamic Acid. This drug comes in the form of Tablet. The general packing available for this medicine consists of 6 Tablet and is priced at Rs 90 (arround $1.26 US Dollar)
Generic (Salt) Combination :
(Mefenamic Acid+ Tranexamic Acid)
Pharma Company :
Blue Cross Laboratories Ltd.
Brand Label :
Meftal TX (250+500)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
Tranexamic Acid-500 mg
Mefenamic Acid-250 mg
Pack Size/Qty/Vol :
6 Tablet
Price Unit :
Rs 15 INR (arround $0.21 US Dollar)
Price Pack :
Rs 90 INR (arround $1.26 US Dollar)
Drug details for Meftal TX (250+500)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Meftal TX (250+500) are :
Tranexamic Acid-500 mg
Mefenamic Acid-250 mg
Mefenamic Acid Indication (Prescribed for or used as): Mefenamic acid is used to relieve mild to moderate pain, including menstrual pain (pain that happens before or during a menstrual period). Mefenamic acid is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.
For more details on Mefenamic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Mefenamic Acid..
Tranexamic Acid Indication (Prescribed for or used as): Tranexamic acid is used to treat heavy bleeding during the menstrual cycle (monthly periods) in women. Tranexamic acid is in a class of medications called antifibrinolytics. It works to improve blood clotting.Short term management of haemorrhage. Long-term management of hereditary angioedema.
For more details on Tranexamic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Tranexamic Acid..
Meftal TX (250+500) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 25 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Meftal TX (250+500), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Tranexamic Acid-500 mg Mefenamic Acid-250 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
Meftal TX (250+500) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Blue Cross Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Tranexamic Acid, Mefenamic Acid. This drug comes in the form of Tablet. The general packing available for this medicine consists of 6 Tablet and is priced at Rs 90 (arround $1.26 US Dollar)
Generic (Salt) Combination :
(Tranexamic Acid+ Mefenamic Acid)
Pharma Company :
Blue Cross Laboratories Ltd.
Brand Label :
Meftal TX (250+500)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
Mefenamic Acid-250 mg
Tranexamic Acid-500 mg
Pack Size/Qty/Vol :
6 Tablet
Price Unit :
Rs 15 INR (arround $0.21 US Dollar)
Price Pack :
Rs 90 INR (arround $1.26 US Dollar)
Drug details for Meftal TX (250+500)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Meftal TX (250+500) are :
Mefenamic Acid-250 mg
Tranexamic Acid-500 mg
Tranexamic Acid Indication (Prescribed for or used as): Tranexamic acid is used to treat heavy bleeding during the menstrual cycle (monthly periods) in women. Tranexamic acid is in a class of medications called antifibrinolytics. It works to improve blood clotting.
Short term management of haemorrhage. Long-term management of hereditary angioedema.
For more details on Tranexamic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Tranexamic Acid..
Mefenamic Acid Indication (Prescribed for or used as): Mefenamic acid is used to relieve mild to moderate pain, including menstrual pain (pain that happens before or during a menstrual period). Mefenamic acid is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.Analgesic. Dysmenorrhoea. Rheumatoid arthritis. Osteoarthritis. Antipyretic. Menorrhagia.
For more details on Mefenamic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Mefenamic Acid..
Meftal TX (250+500) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 100 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Meftal TX (250+500), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Mefenamic Acid-250 mg Tranexamic Acid-500 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.